Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Cash & Current Investments (2016 - 2025)

Skinvisible's Cash & Current Investments history spans 15 years, with the latest figure at $645.0 for Q3 2025.

  • For Q3 2025, Cash & Current Investments rose 5.39% year-over-year to $645.0; the TTM value through Sep 2025 reached $645.0, up 5.39%, while the annual FY2024 figure was $10336.0, 1063.96% up from the prior year.
  • Cash & Current Investments for Q3 2025 was $645.0 at Skinvisible, up from $120.0 in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $245644.0 in Q2 2021 and bottomed at $120.0 in Q2 2025.
  • The 5-year median for Cash & Current Investments is $12667.0 (2021), against an average of $50185.3.
  • The largest annual shift saw Cash & Current Investments surged 1257.53% in 2021 before it crashed 99.43% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $66037.0 in 2021, then rose by 23.23% to $81378.0 in 2022, then plummeted by 98.91% to $888.0 in 2023, then surged by 1063.96% to $10336.0 in 2024, then crashed by 93.76% to $645.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Cash & Current Investments are $645.0 (Q3 2025), $120.0 (Q2 2025), and $13396.0 (Q1 2025).